We are live on ! Find out more
WA

WestEnd Advisors Portfolio holdings

AUM $4.14B
1-Year Est. Return 15.99%
This Fund
S&P 500
This Quarter Est. Return
-0.98%
1 Year Est. Return
+15.99%
3 Year Est. Return
+49.16%
5 Year Est. Return
+46.23%
10 Year Est. Return
+187.39%
AUM
$1.88B
AUM Growth
-$178M
Cap. Flow
-$136M
Cap. Flow %
-7.24%
Top 10 Hldgs %
50.4%
Holding
37
New
5
Increased
14
Reduced
13
Closed
5

Top Sells

1
JWN
Nordstrom
JWN
+$107M
2
NKE icon
Nike
NKE
+$103M
3
COST icon
Costco
COST
+$102M
4
QCOM icon
Qualcomm
QCOM
+$102M
5
EBAY icon
eBay
EBAY
+$99.8M

Sector Composition

1 Healthcare 39.51%
2 Consumer Staples 20.22%
3 Communication Services 14.87%
4 Technology 9.8%
5 Financials 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KHC icon
1
Kraft Heinz
KHC
$31.1B
$97.3M 5.17%
+1,100,048
New +$90.5M
CMCSA icon
2
Comcast
CMCSA
$86.1B
$96.7M 5.13%
2,965,880
-380,698
-11% -$11.8M
KR icon
3
Kroger
KR
$35.9B
$95.8M 5.09%
+2,604,291
New +$93.7M
TJX icon
4
TJX Companies
TJX
$171B
$95.1M 5.05%
2,464,056
-241,364
-9% -$9.21M
BMY icon
5
Bristol-Myers Squibb
BMY
$124B
$95M 5.04%
+1,291,045
New +$91.2M
UNH icon
6
UnitedHealth
UNH
$384B
$94.8M 5.03%
+671,456
New +$89.5M
DLTR icon
7
Dollar Tree
DLTR
$24.7B
$94.6M 5.02%
+1,004,164
New +$84.9M
BIIB icon
8
Biogen
BIIB
$30.8B
$93.6M 4.97%
386,911
+17,212
+5% +$4.54M
GILD icon
9
Gilead Sciences
GILD
$169B
$93.3M 4.95%
1,118,400
+35,826
+3% +$3.18M
CVS icon
10
CVS Health
CVS
$136B
$93.3M 4.95%
974,347
-22,516
-2% -$2.24M
EL icon
11
Estee Lauder
EL
$30B
$93.2M 4.94%
1,023,475
-57,647
-5% -$5.38M
DIS icon
12
Walt Disney
DIS
$173B
$93.1M 4.94%
952,234
-65,671
-6% -$6.57M
ADBE icon
13
Adobe
ADBE
$93.5B
$93M 4.94%
970,865
-221,797
-19% -$21.3M
PYPL icon
14
PayPal
PYPL
$50B
$92.9M 4.93%
2,543,614
-118,065
-4% -$4.51M
HCA icon
15
HCA Healthcare
HCA
$85.6B
$92.4M 4.9%
1,199,295
-227,782
-16% -$18M
CELG
16
DELISTED
Celgene Corp
CELG
$91.9M 4.88%
931,389
+2,682
+0.3% +$277K
AAPL icon
17
Apple
AAPL
$4.89T
$91.7M 4.87%
3,836,416
-134,720
-3% -$3.35M
GOOGL icon
18
Alphabet (Google) Class A
GOOGL
$4.33T
$90.3M 4.79%
2,566,720
-95,020
-4% -$3.49M
AGN
19
DELISTED
Allergan plc
AGN
$90.3M 4.79%
390,635
+48,425
+14% +$11.2M
MA icon
20
Mastercard
MA
$487B
$88.1M 4.67%
1,000,099
-112,311
-10% -$10.7M
XLV icon
21
State Street Health Care Select Sector SPDR ETF
XLV
$41.4B
$3.42M 0.18%
47,692
+21,658
+83% +$1.53M
VEU icon
22
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$3.39M 0.18%
79,168
+19,416
+32% +$841K
XLK icon
23
State Street Technology Select Sector SPDR ETF
XLK
$114B
$2.42M 0.13%
111,780
+9,616
+9% +$209K
XLP icon
24
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$2.03M 0.11%
36,821
+16,767
+84% +$892K
XLY icon
25
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.3B
$1.93M 0.1%
49,468
-8,196
-14% -$322K

Similar funds

WestEnd Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, WestEnd Advisors held 37 positions worth $1.88B, down 8.6% from $2.06B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

WestEnd Advisors withdrew a net $136M in Q2 2016, closing 5 positions and reducing 13 holdings. Its most notable exit was Nordstrom, an estimated $107M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 29% a quarter earlier, followed by Consumer Staples and Communication Services.

Against the trend, WestEnd Advisors opened a new position in Kroger worth $95.8M.

  • WestEnd Advisors's largest Q2 2016 buy was Kroger: 2,604,291 shares worth $95.8M.
  • WestEnd Advisors added most to Allergan plc in Q2 2016, an estimated $11.2M increase.
  • WestEnd Advisors's biggest Q2 2016 reduction was Adobe, cutting an estimated $21.3M.
  • WestEnd Advisors fully exited Nordstrom in Q2 2016, selling an estimated $107M.
  • WestEnd Advisors's ten largest holdings make up 50% of its $1.88B portfolio in Q2 2016.
  • WestEnd Advisors opened 5 new positions and closed 5 in Q2 2016.
  • WestEnd Advisors's portfolio value fell 8.6% quarter-over-quarter to $1.88B.

Based on WestEnd Advisors's 13F filing for Q2 2016, filed 29 Jul 2016.